Cargando…
Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda
Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467908/ https://www.ncbi.nlm.nih.gov/pubmed/32277309 http://dx.doi.org/10.1007/s10461-020-02838-w |
_version_ | 1783578109205807104 |
---|---|
author | Abaasa, Andrew Nash, Stephen Mayanja, Yunia Price, Matt A. Fast, Patricia E. Kaleebu, Pontiano Todd, Jim |
author_facet | Abaasa, Andrew Nash, Stephen Mayanja, Yunia Price, Matt A. Fast, Patricia E. Kaleebu, Pontiano Todd, Jim |
author_sort | Abaasa, Andrew |
collection | PubMed |
description | Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks and female sex workers in Uganda to evaluate this difference. We screened observational cohort participants for enrolment into SiVETs, until 572 were enrolled. Those not enrolled (n = 953) continued participation in the observational cohorts. We determined risk behaviors at baseline and at 1 year, assigned a numeric score to each behavior and defined composite score as the sum of reported behaviors. We compared changes in scores over 12 months. Both observational cohorts and SiVETs saw a significant decrease in score but greatest in the SiVETs. Investigators recruiting for trials from these populations should consider the likely effect of reduction in risk behaviors on incident HIV infection and trial statistical power. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10461-020-02838-w) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7467908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-74679082020-09-15 Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda Abaasa, Andrew Nash, Stephen Mayanja, Yunia Price, Matt A. Fast, Patricia E. Kaleebu, Pontiano Todd, Jim AIDS Behav Original Paper Many key populations have high-risk behaviors for HIV infection making them suitable for HIV vaccine efficacy trials. However, these behaviors may change when participants enroll into a trial. We used HIV simulated vaccine efficacy trials (SiVETs) nested within observational cohorts of fisherfolks and female sex workers in Uganda to evaluate this difference. We screened observational cohort participants for enrolment into SiVETs, until 572 were enrolled. Those not enrolled (n = 953) continued participation in the observational cohorts. We determined risk behaviors at baseline and at 1 year, assigned a numeric score to each behavior and defined composite score as the sum of reported behaviors. We compared changes in scores over 12 months. Both observational cohorts and SiVETs saw a significant decrease in score but greatest in the SiVETs. Investigators recruiting for trials from these populations should consider the likely effect of reduction in risk behaviors on incident HIV infection and trial statistical power. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10461-020-02838-w) contains supplementary material, which is available to authorized users. Springer US 2020-04-10 2020 /pmc/articles/PMC7467908/ /pubmed/32277309 http://dx.doi.org/10.1007/s10461-020-02838-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Abaasa, Andrew Nash, Stephen Mayanja, Yunia Price, Matt A. Fast, Patricia E. Kaleebu, Pontiano Todd, Jim Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title | Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title_full | Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title_fullStr | Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title_full_unstemmed | Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title_short | Comparison of HIV Risk Behaviors Between Clinical Trials and Observational Cohorts in Uganda |
title_sort | comparison of hiv risk behaviors between clinical trials and observational cohorts in uganda |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467908/ https://www.ncbi.nlm.nih.gov/pubmed/32277309 http://dx.doi.org/10.1007/s10461-020-02838-w |
work_keys_str_mv | AT abaasaandrew comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT nashstephen comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT mayanjayunia comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT pricematta comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT fastpatriciae comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT kaleebupontiano comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda AT toddjim comparisonofhivriskbehaviorsbetweenclinicaltrialsandobservationalcohortsinuganda |